Renown said the increase was due to the “growth in overall operating revenues significantly outpacing the increase in operating expenses.”
The system saw operating revenues of $497.1 million for the quarter ended March 31, up 17.5% year over year. Renown attributed the jump in revenues primarily to an increase in patient service revenues.
Total expenses were $464.7 million, up 9.3% year over year. Salaries and wages decreased from $183.3 million in the first quarter of 2023 to $176.1 million in the first quarter of 2024. Supply costs rose from $70.2 million in the first quarter of 2023 to $80.5 million in 2024.
Renown posted a net income of $69.7 million in the quarter, up from a net income of $32.5 in the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
